Recent Company News

• 07:41 PM ET Sep 17, 2025
  

  Olympus downgraded to underperform from neutral at BofA (¥1867.5000, 0)

• 10:50 PM ET Aug 31, 2025
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 05:49 PM ET Aug 26, 2025
  

  Olympus downgraded to neutral from buy at BofA (¥1728.0000, 0)

• 06:28 PM ET Aug 10, 2025
  

  Olympus downgraded to hold from outperform at CLSA (¥1824.5000, 0)

• 02:56 AM ET Aug 08, 2025
  

  StreetAccount Metrics Recap - Olympus Q1 Earnings (¥1824.5000, 0)

• 02:37 AM ET Aug 08, 2025
  

  Olympus reports Q1 net income attributable ¥8.99B vs StreetAccount ¥17.80B [5 est, ¥16.07-20.90B] (¥1824.5000, 0)

• 03:26 AM ET Aug 07, 2025
  

  StreetAccount Consensus Metrics Preview - Olympus Q1 Earnings (¥1791.5000, 0)

• 11:54 PM ET Aug 02, 2025
  

  Olympus downgraded to neutral from outperform at Macquarie (¥1824.5000, 0)

• 03:30 AM ET Jul 25, 2025
  

  Olympus to invest in Revival Healthcare Capital's medical device firm Swan EndoSurgical (¥1787.5000, 0)

• 03:50 AM ET Jun 30, 2025
  

  Olympus acknowledges FDA import alerts for certain devices manufactured at Aizu facility, Japan (¥1715.0000, 0)